Oncotarget

Research Papers:

Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation

Cheng Yajun, Ye Chen, Li Xiaosa, Wang Xiao, Chen Jia, Wang Zhong and Xu Bin _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:89620-89630. https://doi.org/10.18632/oncotarget.19210

Metrics: PDF 801 views  |   HTML 1571 views  |   ?  


Abstract

Cheng Yajun1,*, Ye Chen2,*, Li Xiaosa3,*, Wang Xiao3, Chen Jia3, Wang Zhong1 and Xu Bin1

1Department of Urology, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

2Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China

3School of Life Science and Technology, ShanghaiTech University, Shanghai, China

*These authors contributed equally to this work

Correspondence to:

Xu Bin, email: chxb2004@126.com

Wang Zhong, email: zhongwang2000@sina.com

Chen Jia, email: chenjia@shanghaitech.edu.cn

Keywords: prostate cancer, fatty acid oxidation, Sun2, SAA1, overall survival

Received: April 18, 2017     Accepted: June 28, 2017     Published: July 12, 2017

ABSTRACT

The role of Sun2 has been described by previous studies in various types of cancers, including breast cancer and lung cancer. However, its role and potential molecular mechanism in the progression of prostate cancer have not been fully elucidated. In the present study, we found that Sun2 expression was reduced in prostate cancer tissues compared with paired normal tissues, and that low expression of Sun2 was significantly correlated with Higher Gleason scores, postoperative T stage (pT), Lymph nodal invasion and Clinical pathological stages. In addition, reduced Sun2 Expression predicts poor survival of prostate cancer patients and could serve as an independent predictor of prostate cancer patients overall survival (OS).Furthermore, Sun2 overexpression inhibits the prostate cancer cells growth, and Sun2 knockdown promotes the prostate cancer cells growth both in vitro and vivo. Mechanical silencing of , Sun2 promoted fatty acid oxidation (FAO) in prostate cancer, prostate cancer cells growth promoted by Sun2 silencing could be reversed by the FAO inhibitor Etomoxir. Additionally, we also showed that serum amyloid A1 (SAA1) play a vital role in FAO, ATP and cell growth promoted by Sun2 loss in prostate cancer. These results suggest that Loss of Sun2 promoted the prostate cancer progression by regulating FAO.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 19210